|
|||||
|
|
Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. |
|
| Authors: | Flore Sicre de Fontbrune Marie Robin Raphael Porcher Catherine Scieux Régis Peffault de Latour Christèle Ferry Vanderson Rocha Karim Boudjedir Agnès Devergie Anne Bergeron Eliane Gluckman Elie Azoulay Jordane Lapalu Gérard Socié Patricia Ribaud |
| Affiliation: | Hematologie-Greffe, Université Paris 7, Assistance Publique-H?pitaux de Paris, H?pital Saint-Louis, Paris, France. |
| Abstract: | Among 40 allogeneic stem cell transplant recipients who developed symptomatic respiratory syncytial virus infection, including 22 patients with lower respiratory tract infection, 19 received palivizumab (9 of whom had upper respiratory tract disease). Palivizumab did not prevent progression to lower respiratory infection and had no impact on the overall survival rate. |
| Keywords: | |